

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.35918986 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.13130835 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.13130835 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.13130835 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.13130835 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.13130835 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.13130835 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.70565641 |
| 9 | response to peptidoglycan (GO:0032494) | 4.41527253 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 4.15182028 |
| 11 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.94928681 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 3.92162824 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.90677054 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85397873 |
| 15 | detection of bacterium (GO:0016045) | 3.83560816 |
| 16 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.80519395 |
| 17 | cellular extravasation (GO:0045123) | 3.74908361 |
| 18 | respiratory burst (GO:0045730) | 3.66880778 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61757353 |
| 20 | granulocyte activation (GO:0036230) | 3.58892580 |
| 21 | response to host immune response (GO:0052572) | 3.58888701 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58888701 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58184430 |
| 24 | neutrophil activation (GO:0042119) | 3.55834909 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.54572172 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.54102425 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.50178159 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48081141 |
| 29 | regulation of mast cell activation (GO:0033003) | 3.46881728 |
| 30 | microglial cell activation (GO:0001774) | 3.45972326 |
| 31 | * positive regulation of cellular amide metabolic process (GO:0034250) | 3.45427346 |
| 32 | reactive oxygen species biosynthetic process (GO:1903409) | 3.44369770 |
| 33 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.42717891 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.41149237 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38307042 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.35401606 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33656114 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.31498176 |
| 39 | type I interferon signaling pathway (GO:0060337) | 3.29963134 |
| 40 | cellular response to type I interferon (GO:0071357) | 3.29963134 |
| 41 | response to type I interferon (GO:0034340) | 3.29722755 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.28329708 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23441356 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23441356 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22842972 |
| 46 | superoxide anion generation (GO:0042554) | 3.22377481 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21768628 |
| 48 | response to host (GO:0075136) | 3.21768628 |
| 49 | response to host defenses (GO:0052200) | 3.21768628 |
| 50 | T-helper 1 type immune response (GO:0042088) | 3.21677679 |
| 51 | macrophage activation (GO:0042116) | 3.18181937 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17154991 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15802412 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.13817077 |
| 55 | positive regulation of humoral immune response (GO:0002922) | 3.09719490 |
| 56 | positive regulation of heat generation (GO:0031652) | 3.07264061 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06785388 |
| 58 | germinal center formation (GO:0002467) | 3.06601730 |
| 59 | leukocyte aggregation (GO:0070486) | 3.01734572 |
| 60 | defense response to protozoan (GO:0042832) | 3.00526003 |
| 61 | positive regulation of interferon-beta production (GO:0032728) | 3.00407140 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.00010191 |
| 63 | negative regulation of lipid storage (GO:0010888) | 2.99431460 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98112855 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 2.97843541 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 2.96295475 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96192196 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95955281 |
| 69 | regulation of tolerance induction (GO:0002643) | 2.94321846 |
| 70 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.93317158 |
| 71 | cellular response to exogenous dsRNA (GO:0071360) | 2.93279763 |
| 72 | positive regulation of interleukin-12 production (GO:0032735) | 2.91758960 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91618405 |
| 74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90325770 |
| 75 | cellular response to interferon-beta (GO:0035458) | 2.89960188 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87588423 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 2.86431509 |
| 78 | positive thymic T cell selection (GO:0045059) | 2.83436977 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83092476 |
| 80 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82829672 |
| 81 | natural killer cell mediated immunity (GO:0002228) | 2.82829672 |
| 82 | detection of external biotic stimulus (GO:0098581) | 2.82718833 |
| 83 | leukocyte mediated cytotoxicity (GO:0001909) | 2.80861771 |
| 84 | T cell migration (GO:0072678) | 2.80404652 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80352554 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79004648 |
| 87 | regulation of activation of Janus kinase activity (GO:0010533) | 2.78955994 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 2.77947129 |
| 89 | regulation of fever generation (GO:0031620) | 2.77693324 |
| 90 | positive regulation of type 2 immune response (GO:0002830) | 2.77594498 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 2.74423880 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73821845 |
| 93 | regulation of B cell differentiation (GO:0045577) | 2.73337484 |
| 94 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72814233 |
| 95 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72511251 |
| 96 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.71996765 |
| 97 | negative thymic T cell selection (GO:0045060) | 2.71599763 |
| 98 | cellular response to ethanol (GO:0071361) | 2.70099245 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69847751 |
| 100 | neutrophil mediated immunity (GO:0002446) | 2.69457259 |
| 101 | regulation of mononuclear cell migration (GO:0071675) | 2.69069516 |
| 102 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69002392 |
| 103 | positive regulation of mast cell degranulation (GO:0043306) | 2.69002392 |
| 104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.68471784 |
| 105 | negative regulation of viral genome replication (GO:0045071) | 2.68213168 |
| 106 | regulation of type 2 immune response (GO:0002828) | 2.67791733 |
| 107 | detection of other organism (GO:0098543) | 2.67620603 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 2.67356993 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 2.67053222 |
| 110 | I-kappaB phosphorylation (GO:0007252) | 2.66213113 |
| 111 | cytokine secretion (GO:0050663) | 2.65900965 |
| 112 | detection of biotic stimulus (GO:0009595) | 2.65440792 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.65317799 |
| 114 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65317799 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.65245821 |
| 116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65039198 |
| 117 | negative regulation of interleukin-12 production (GO:0032695) | 2.64746863 |
| 118 | regulation of hypersensitivity (GO:0002883) | 2.64614108 |
| 119 | response to interferon-alpha (GO:0035455) | 2.63403999 |
| 120 | response to protozoan (GO:0001562) | 2.62744544 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62291587 |
| 122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.62117423 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.60706689 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.60196247 |
| 125 | cellular response to interferon-gamma (GO:0071346) | 2.59939371 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.59494178 |
| 127 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59169091 |
| 128 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.59060003 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.58975414 |
| 130 | regulation of RIG-I signaling pathway (GO:0039535) | 2.58706864 |
| 131 | B cell mediated immunity (GO:0019724) | 2.58506283 |
| 132 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.58478935 |
| 133 | myeloid leukocyte activation (GO:0002274) | 2.57658792 |
| 134 | negative T cell selection (GO:0043383) | 2.57488752 |
| 135 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.55678310 |
| 136 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.55678310 |
| 137 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.55372635 |
| 138 | positive regulation of B cell mediated immunity (GO:0002714) | 2.55372635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.50747621 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.94884396 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.35062011 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.18557197 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.95319816 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89733046 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71595483 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66500576 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.48881228 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18241328 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.18144251 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.11901868 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.88539435 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78476470 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.78378155 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62208776 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51457332 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37191537 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.25303792 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24738751 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18694918 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12698292 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.11354286 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92441754 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88452635 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.82091892 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76736213 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76037523 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66229299 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66144311 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65421636 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64562044 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63623915 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63344287 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63143681 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63092985 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56859649 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55006717 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54741088 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50895143 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50292987 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49087439 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47993819 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46054857 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.42239254 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35992708 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33565235 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29175400 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25593396 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24223869 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23477110 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22583781 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21442350 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21284737 |
| 55 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20831268 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20655102 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20629998 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18406989 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17313248 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16848108 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.16194876 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15629349 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11525621 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10744638 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09636872 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09533411 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09473618 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09015731 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07952949 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07952949 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.07484975 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04710301 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01893413 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00329912 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00177361 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99638820 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99622490 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99470728 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96166498 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94328346 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 0.94174249 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90842508 |
| 83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90031659 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88782950 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88161691 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87688199 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.87237434 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86851830 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86317207 |
| 90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86277232 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84502696 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83236755 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81877899 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81749466 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80152251 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78545507 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76889892 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75365458 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75232800 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74607636 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73870104 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.73140945 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73136443 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72650896 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72594697 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71236398 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.70873662 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.70764077 |
| 109 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.68108888 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.67858249 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67737302 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.66804930 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.65946661 |
| 114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65716294 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65609566 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.64869706 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.64567658 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63532914 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63468337 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63190290 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.61551927 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61410841 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.60124473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.48934130 |
| 2 | MP0009785_altered_susceptibility_to | 3.56647042 |
| 3 | MP0003436_decreased_susceptibility_to | 3.39880266 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.07348679 |
| 5 | MP0006082_CNS_inflammation | 3.03689277 |
| 6 | MP0002419_abnormal_innate_immunity | 2.95203870 |
| 7 | MP0003724_increased_susceptibility_to | 2.85319249 |
| 8 | MP0000685_abnormal_immune_system | 2.78343828 |
| 9 | MP0005025_abnormal_response_to | 2.77345132 |
| 10 | MP0005387_immune_system_phenotype | 2.76349008 |
| 11 | MP0001790_abnormal_immune_system | 2.76349008 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.71411173 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.59467352 |
| 14 | MP0005671_abnormal_response_to | 2.48571128 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.36648627 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.34640816 |
| 17 | MP0001800_abnormal_humoral_immune | 2.28816955 |
| 18 | MP0002723_abnormal_immune_serum | 2.27622480 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.26695190 |
| 20 | MP0004782_abnormal_surfactant_physiolog | 2.20998213 |
| 21 | MP0009764_decreased_sensitivity_to | 2.20025341 |
| 22 | MP0009840_abnormal_foam_cell | 2.18400860 |
| 23 | MP0004510_myositis | 2.12597306 |
| 24 | MP0003303_peritoneal_inflammation | 2.11746076 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.08455470 |
| 26 | MP0005360_urolithiasis | 1.99548495 |
| 27 | MP0001819_abnormal_immune_cell | 1.99276800 |
| 28 | MP0001853_heart_inflammation | 1.97940044 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.95694601 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.88336901 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 1.82380063 |
| 32 | MP0008469_abnormal_protein_level | 1.80827909 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.75540140 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.73932536 |
| 35 | MP0002405_respiratory_system_inflammati | 1.72897973 |
| 36 | MP0005365_abnormal_bile_salt | 1.71527286 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.68668769 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.68658886 |
| 39 | MP0004947_skin_inflammation | 1.67127195 |
| 40 | MP0002006_tumorigenesis | 1.54400607 |
| 41 | MP0002254_reproductive_system_inflammat | 1.50020050 |
| 42 | MP0008004_abnormal_stomach_pH | 1.49140855 |
| 43 | MP0005083_abnormal_biliary_tract | 1.46938227 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.45427492 |
| 45 | MP0003075_altered_response_to | 1.44079077 |
| 46 | MP0003195_calcinosis | 1.43035316 |
| 47 | MP0000716_abnormal_immune_system | 1.40561716 |
| 48 | MP0003252_abnormal_bile_duct | 1.40370113 |
| 49 | MP0003828_pulmonary_edema | 1.38936136 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.37050043 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35338548 |
| 52 | MP0003448_altered_tumor_morphology | 1.34454383 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.31502695 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.30138369 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.29026397 |
| 56 | MP0004883_abnormal_blood_vessel | 1.28040714 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.27320307 |
| 58 | MP0005166_decreased_susceptibility_to | 1.25458895 |
| 59 | MP0002398_abnormal_bone_marrow | 1.23372891 |
| 60 | MP0003690_abnormal_glial_cell | 1.21895757 |
| 61 | MP0005310_abnormal_salivary_gland | 1.20020187 |
| 62 | MP0000343_altered_response_to | 1.18513422 |
| 63 | MP0003186_abnormal_redox_activity | 1.17973300 |
| 64 | MP0009763_increased_sensitivity_to | 1.16745532 |
| 65 | MP0000604_amyloidosis | 1.16152820 |
| 66 | MP0000858_altered_metastatic_potential | 1.15592625 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.14007426 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.08907949 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.08773398 |
| 70 | MP0003866_abnormal_defecation | 1.08552103 |
| 71 | MP0002429_abnormal_blood_cell | 1.07027122 |
| 72 | MP0000609_abnormal_liver_physiology | 1.06562814 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.05859282 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.05699997 |
| 75 | MP0009278_abnormal_bone_marrow | 1.03570711 |
| 76 | MP0003763_abnormal_thymus_physiology | 0.97908319 |
| 77 | MP0001545_abnormal_hematopoietic_system | 0.96647291 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.96647291 |
| 79 | MP0005451_abnormal_body_composition | 0.95099863 |
| 80 | MP0002722_abnormal_immune_system | 0.92473839 |
| 81 | MP0005164_abnormal_response_to | 0.89991574 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.89756817 |
| 83 | MP0008260_abnormal_autophagy | 0.88207155 |
| 84 | MP0001873_stomach_inflammation | 0.86792259 |
| 85 | MP0009697_abnormal_copulation | 0.84920574 |
| 86 | MP0001958_emphysema | 0.84417291 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 0.82798423 |
| 88 | MP0001851_eye_inflammation | 0.82676017 |
| 89 | MP0001663_abnormal_digestive_system | 0.82433725 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.82395418 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.81335143 |
| 92 | MP0003091_abnormal_cell_migration | 0.78940801 |
| 93 | MP0000249_abnormal_blood_vessel | 0.78300292 |
| 94 | MP0006054_spinal_hemorrhage | 0.77338688 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.76260008 |
| 96 | MP0003045_fibrosis | 0.75510442 |
| 97 | MP0004381_abnormal_hair_follicle | 0.75397842 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75147800 |
| 99 | MP0002332_abnormal_exercise_endurance | 0.74634676 |
| 100 | MP0002132_abnormal_respiratory_system | 0.74471897 |
| 101 | MP0002933_joint_inflammation | 0.73574865 |
| 102 | MP0000371_diluted_coat_color | 0.73342969 |
| 103 | MP0001666_abnormal_nutrient_absorption | 0.73090876 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.73066843 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.70994528 |
| 106 | MP0005332_abnormal_amino_acid | 0.70185403 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.70005523 |
| 108 | MP0005390_skeleton_phenotype | 0.69830474 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.68756196 |
| 110 | MP0000920_abnormal_myelination | 0.67393465 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.65745665 |
| 112 | MP0003795_abnormal_bone_structure | 0.65106718 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.63958839 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.63792956 |
| 115 | MP0001764_abnormal_homeostasis | 0.63759280 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.63152619 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.63073436 |
| 118 | MP0002928_abnormal_bile_duct | 0.62568143 |
| 119 | MP0000598_abnormal_liver_morphology | 0.62308539 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.61888003 |
| 121 | MP0008874_decreased_physiological_sensi | 0.56807847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.31001931 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.10626837 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.05071062 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.00925593 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.56628847 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.51445246 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.05358108 |
| 8 | Recurrent skin infections (HP:0001581) | 4.04259649 |
| 9 | Joint hemorrhage (HP:0005261) | 3.95364118 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.95353071 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84744930 |
| 12 | Gingivitis (HP:0000230) | 3.75380017 |
| 13 | Myositis (HP:0100614) | 3.66154033 |
| 14 | Orchitis (HP:0100796) | 3.61837236 |
| 15 | Stomatitis (HP:0010280) | 3.60356837 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.55725050 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.55306707 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.53955618 |
| 19 | Optic neuritis (HP:0100653) | 3.53955618 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.47048669 |
| 21 | Vasculitis (HP:0002633) | 3.27287228 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 3.17759050 |
| 23 | Gingival bleeding (HP:0000225) | 3.15654926 |
| 24 | Periodontitis (HP:0000704) | 3.13017876 |
| 25 | Myocardial infarction (HP:0001658) | 3.09580175 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01050555 |
| 27 | Obstructive lung disease (HP:0006536) | 3.01050555 |
| 28 | Increased IgM level (HP:0003496) | 2.99789719 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99602316 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99602316 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.98580605 |
| 32 | Recurrent viral infections (HP:0004429) | 2.98522151 |
| 33 | Glomerulonephritis (HP:0000099) | 2.94029905 |
| 34 | Encephalitis (HP:0002383) | 2.93512461 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.90290943 |
| 36 | Petechiae (HP:0000967) | 2.87410386 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.76883074 |
| 38 | Complement deficiency (HP:0004431) | 2.76018187 |
| 39 | Basal ganglia calcification (HP:0002135) | 2.75824482 |
| 40 | Urticaria (HP:0001025) | 2.71815679 |
| 41 | Tetraparesis (HP:0002273) | 2.68684485 |
| 42 | Chronic otitis media (HP:0000389) | 2.65502998 |
| 43 | Pustule (HP:0200039) | 2.64126430 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.60923138 |
| 45 | Meningitis (HP:0001287) | 2.59544522 |
| 46 | Axonal loss (HP:0003447) | 2.59415901 |
| 47 | Chest pain (HP:0100749) | 2.55193740 |
| 48 | Thick nail (HP:0001805) | 2.54026872 |
| 49 | Increased CSF protein (HP:0002922) | 2.53030957 |
| 50 | Prostate neoplasm (HP:0100787) | 2.52002490 |
| 51 | Loss of speech (HP:0002371) | 2.50757317 |
| 52 | Joint swelling (HP:0001386) | 2.48224682 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47885477 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.47885477 |
| 55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47508698 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47508698 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47508698 |
| 58 | Arterial thrombosis (HP:0004420) | 2.47217464 |
| 59 | Abnormality of complement system (HP:0005339) | 2.41678676 |
| 60 | Recurrent pneumonia (HP:0006532) | 2.39003571 |
| 61 | Epistaxis (HP:0000421) | 2.38704884 |
| 62 | Xanthomatosis (HP:0000991) | 2.34851644 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.34454080 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34176347 |
| 65 | Increased serum ferritin (HP:0003281) | 2.33203486 |
| 66 | Gangrene (HP:0100758) | 2.32928205 |
| 67 | Osteomyelitis (HP:0002754) | 2.32429268 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.32249121 |
| 69 | Hemoptysis (HP:0002105) | 2.30122176 |
| 70 | Nephritis (HP:0000123) | 2.28791061 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.28712981 |
| 72 | Amyloidosis (HP:0011034) | 2.27292500 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.26729185 |
| 74 | Leukocytosis (HP:0001974) | 2.25724762 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24847184 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.22774716 |
| 77 | Episodic fever (HP:0001954) | 2.22453745 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20763249 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.20052177 |
| 80 | Menorrhagia (HP:0000132) | 2.19782098 |
| 81 | Polyneuropathy (HP:0001271) | 2.19004003 |
| 82 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.18417719 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.18021035 |
| 84 | Esophageal varix (HP:0002040) | 2.16884788 |
| 85 | Cellulitis (HP:0100658) | 2.16799684 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 2.15842378 |
| 87 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15765782 |
| 88 | Increased IgE level (HP:0003212) | 2.13990546 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.10344927 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.10194256 |
| 91 | Anorexia (HP:0002039) | 2.09557591 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.08961198 |
| 93 | T lymphocytopenia (HP:0005403) | 2.08922479 |
| 94 | Vertigo (HP:0002321) | 2.08823030 |
| 95 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.08374642 |
| 96 | Colitis (HP:0002583) | 2.07969647 |
| 97 | Granulocytopenia (HP:0001913) | 2.07873301 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.07540656 |
| 99 | Bone pain (HP:0002653) | 2.07104572 |
| 100 | Hematochezia (HP:0002573) | 2.06584493 |
| 101 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06158018 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.03814541 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.03042864 |
| 104 | Hyperlipoproteinemia (HP:0010980) | 2.02604182 |
| 105 | Disinhibition (HP:0000734) | 2.02581673 |
| 106 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02485409 |
| 107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02485409 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02485409 |
| 109 | Eosinophilia (HP:0001880) | 2.02185588 |
| 110 | Recurrent bronchitis (HP:0002837) | 2.01927516 |
| 111 | Prolonged bleeding time (HP:0003010) | 2.01284232 |
| 112 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00067034 |
| 113 | Cheilitis (HP:0100825) | 2.00039246 |
| 114 | Hypercholesterolemia (HP:0003124) | 1.99812788 |
| 115 | Keratoconjunctivitis (HP:0001096) | 1.99421968 |
| 116 | Pulmonary embolism (HP:0002204) | 1.98194689 |
| 117 | Hepatosplenomegaly (HP:0001433) | 1.98165401 |
| 118 | Restrictive lung disease (HP:0002091) | 1.97273507 |
| 119 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.96738085 |
| 120 | Chronic diarrhea (HP:0002028) | 1.96698467 |
| 121 | Inflammation of the large intestine (HP:0002037) | 1.95378266 |
| 122 | Thrombophlebitis (HP:0004418) | 1.94216094 |
| 123 | Mitral stenosis (HP:0001718) | 1.93900219 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93185297 |
| 125 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93008828 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.92217537 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 1.91634573 |
| 128 | Epidermoid cyst (HP:0200040) | 1.91200678 |
| 129 | Purpura (HP:0000979) | 1.91174717 |
| 130 | Pathologic fracture (HP:0002756) | 1.90698382 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.89650042 |
| 132 | Prolonged neonatal jaundice (HP:0006579) | 1.88742641 |
| 133 | Abnormality of T cells (HP:0002843) | 1.86160504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.88748455 |
| 2 | IRAK3 | 3.36895173 |
| 3 | TBK1 | 3.31975689 |
| 4 | TYK2 | 3.30641367 |
| 5 | RIPK4 | 3.26110826 |
| 6 | IRAK4 | 3.22994766 |
| 7 | IKBKE | 3.07458314 |
| 8 | TXK | 2.81219332 |
| 9 | BLK | 2.76690020 |
| 10 | JAK3 | 2.53734289 |
| 11 | MAP4K1 | 2.43113680 |
| 12 | IKBKB | 2.38151525 |
| 13 | JAK1 | 2.30878994 |
| 14 | KIT | 2.05020895 |
| 15 | MAP3K13 | 1.96608223 |
| 16 | TAOK3 | 1.96022653 |
| 17 | PBK | 1.83731617 |
| 18 | CSK | 1.75873516 |
| 19 | CHUK | 1.72477958 |
| 20 | GRK6 | 1.69965995 |
| 21 | ERN1 | 1.67561398 |
| 22 | ZAP70 | 1.66597892 |
| 23 | FGFR4 | 1.63592100 |
| 24 | TGFBR2 | 1.54101985 |
| 25 | TNK2 | 1.47336908 |
| 26 | NEK9 | 1.46592392 |
| 27 | PRPF4B | 1.40846129 |
| 28 | BMPR2 | 1.39521103 |
| 29 | TEC | 1.35482391 |
| 30 | BTK | 1.28502161 |
| 31 | CSF1R | 1.25897167 |
| 32 | SYK | 1.24230256 |
| 33 | HCK | 1.23727303 |
| 34 | LYN | 1.18098353 |
| 35 | EPHB1 | 1.13104008 |
| 36 | CDC42BPA | 1.11632051 |
| 37 | IRAK1 | 1.08942709 |
| 38 | SIK3 | 1.08921498 |
| 39 | LCK | 1.08731676 |
| 40 | FGFR3 | 1.08292671 |
| 41 | JAK2 | 1.07616960 |
| 42 | EIF2AK2 | 1.07593803 |
| 43 | FRK | 1.06818680 |
| 44 | ACVR1B | 1.00190552 |
| 45 | MAP3K1 | 0.98735180 |
| 46 | MARK3 | 0.97129736 |
| 47 | RIPK1 | 0.96343267 |
| 48 | FGR | 0.95929528 |
| 49 | INSRR | 0.95004931 |
| 50 | SIK1 | 0.94834497 |
| 51 | TGFBR1 | 0.91399774 |
| 52 | PIM1 | 0.90619785 |
| 53 | CAMKK2 | 0.89172308 |
| 54 | PDK1 | 0.88237487 |
| 55 | ITK | 0.87908696 |
| 56 | RPS6KA4 | 0.87492871 |
| 57 | PIM2 | 0.86013230 |
| 58 | YES1 | 0.85624955 |
| 59 | MAP2K6 | 0.84607102 |
| 60 | EPHA3 | 0.80415194 |
| 61 | CDK8 | 0.79885034 |
| 62 | GRK7 | 0.78926142 |
| 63 | MST1R | 0.76713478 |
| 64 | DAPK2 | 0.76054741 |
| 65 | NLK | 0.74861683 |
| 66 | IRAK2 | 0.74571902 |
| 67 | ABL2 | 0.74386101 |
| 68 | ERBB3 | 0.73526055 |
| 69 | STK10 | 0.73277482 |
| 70 | STK24 | 0.72955217 |
| 71 | TAOK1 | 0.70376598 |
| 72 | MAP3K2 | 0.69041807 |
| 73 | PRKCD | 0.69008986 |
| 74 | MAP3K11 | 0.67888075 |
| 75 | PIK3CG | 0.67826614 |
| 76 | PRKCQ | 0.67567110 |
| 77 | MST4 | 0.67559781 |
| 78 | FLT3 | 0.66850963 |
| 79 | BMPR1B | 0.66039287 |
| 80 | ABL1 | 0.63156215 |
| 81 | ERBB4 | 0.62593311 |
| 82 | CDK9 | 0.62509503 |
| 83 | STK4 | 0.62178866 |
| 84 | MAP2K3 | 0.62150613 |
| 85 | MATK | 0.62112643 |
| 86 | EGFR | 0.60992381 |
| 87 | MAP3K7 | 0.59969008 |
| 88 | FES | 0.59941894 |
| 89 | MAPK12 | 0.59552860 |
| 90 | ADRBK2 | 0.57048333 |
| 91 | HIPK2 | 0.55761007 |
| 92 | BMX | 0.55013126 |
| 93 | TAOK2 | 0.54159654 |
| 94 | CDK6 | 0.54062377 |
| 95 | MAPK7 | 0.53194833 |
| 96 | CLK1 | 0.52987376 |
| 97 | TIE1 | 0.52882117 |
| 98 | PTK6 | 0.52308264 |
| 99 | TRPM7 | 0.51958366 |
| 100 | PTK2B | 0.50439251 |
| 101 | MAP3K12 | 0.49385432 |
| 102 | IGF1R | 0.49140173 |
| 103 | MARK2 | 0.47891078 |
| 104 | NUAK1 | 0.47766919 |
| 105 | SGK3 | 0.43526766 |
| 106 | STK3 | 0.42235088 |
| 107 | CAMK1D | 0.40333844 |
| 108 | SIK2 | 0.39662435 |
| 109 | GRK1 | 0.39254415 |
| 110 | MOS | 0.37557214 |
| 111 | MUSK | 0.37062297 |
| 112 | MAP3K5 | 0.36763337 |
| 113 | MAPK11 | 0.36392232 |
| 114 | MAP3K3 | 0.36353067 |
| 115 | NME2 | 0.35519589 |
| 116 | KSR2 | 0.34843609 |
| 117 | MAPKAPK2 | 0.34782296 |
| 118 | SGK2 | 0.34367028 |
| 119 | PKN1 | 0.32936909 |
| 120 | PRKG2 | 0.31965698 |
| 121 | STK38 | 0.31884582 |
| 122 | PRKD2 | 0.30470708 |
| 123 | RET | 0.29931285 |
| 124 | PRKAA2 | 0.29726898 |
| 125 | PDGFRB | 0.26542028 |
| 126 | RPS6KA6 | 0.26521645 |
| 127 | FYN | 0.26155134 |
| 128 | PIK3CA | 0.23531738 |
| 129 | MAPK4 | 0.22797212 |
| 130 | PDPK1 | 0.22462418 |
| 131 | KDR | 0.22298105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.48908920 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27090555 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87737277 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.56447999 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.51982112 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49886025 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28527518 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.17990949 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.11268097 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.09240953 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07263443 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06445148 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06220307 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.02548173 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00412505 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.95274806 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.94315634 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88951274 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88186242 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.75650133 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65118194 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61352210 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.60164861 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.56643347 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53577522 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.49532257 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.47225070 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46741236 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.43728221 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39377489 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32096281 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30941347 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30600585 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28703617 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.24466083 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22567435 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.20828857 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20497423 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19332958 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17584486 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16866820 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15660839 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14759489 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10536876 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.06107034 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04571827 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04517493 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03071764 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02716930 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.02523464 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01501140 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.00744988 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95979913 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.95513229 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94027444 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85198304 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 0.82781200 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82467561 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81847060 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79004788 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78792082 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78520527 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75746125 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.75390346 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74840947 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73090449 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71417336 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70554531 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70469367 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70158079 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69287381 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68066436 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65930792 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.65595366 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58859859 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57583263 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57130240 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57098874 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56052297 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.55552924 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54344632 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54207002 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53935610 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51445635 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49495523 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49414891 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49408448 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48943807 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47392085 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47315120 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45716271 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44290254 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43966186 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43360271 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42631301 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.41899647 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41223539 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40485870 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39537663 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39530595 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38937438 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37376542 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36512636 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.34593995 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34545259 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34401324 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33979063 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33443529 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32562125 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32192626 |
| 111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32008646 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31922480 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31417880 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30634626 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29742653 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29547733 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28038345 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.27943235 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27445477 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.27170028 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25657274 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25084472 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24567444 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24499229 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.24284175 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23915267 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22718981 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22506405 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22119432 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22099531 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21731071 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20448577 |

